3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Hepatocellular
38
Neoplasm Metastasis
14
Liver Neoplasms
11
Colorectal Neoplasms
11
Cholangiocarcinoma
9
Pancreatic Neoplasms
8
Lung Neoplasms
8
Colonic Neoplasms
7
Breast Neoplasms
7
Thyroid Nodule
6
Recurrence
6
Carcinoma, Renal Cell
6
Carcinoma, Non-Small-Cell Lung
6
Thyroid Neoplasms
5
Rectal Neoplasms
4
Neoplasms
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Pain
3
Kidney Neoplasms
3
Barrett Esophagus
3
Agnosia
3
Thyroid Diseases
2
Thyroid Cancer, Papillary
2
Leiomyoma
2
Hyperaldosteronism
2
Gallbladder Neoplasms
2
Cancer Pain
2
Bile Duct Neoplasms
2
Adrenocortical Adenoma
2
Interventions
Everolimus
5
Temozolomide
4
sargramostim
2
montanide ISA 51
2
lutetium Lu 177 dotatate
2
incomplete Freund's adjuvant
2
Sunitinib
2
Specimen Handling
2
Sorafenib
2
Octreotide
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Fluorouracil
2
Cytoreduction Surgical Procedures
2
Colony-Stimulating Factors
2
Bevacizumab
2
surufatinib
1
recombinant interferon alpha 2b-like protein
1
pentetreotide
1
pasireotide
1
nimotuzumab
1
ibrutinib
1
ganitumab
1
gallium Ga 68 dotatate
1
fludarabine phosphate
1
cabozantinib
1
atezolizumab
1
abemaciclib
1
Wound Healing
1
Thalidomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenoma, Islet Cell
×
Radiofrequency Ablation
×
Clear all
NCT04520932
2025-05-25
RFANET
Institut Paoli-Calmettes
Phase NA
Recruiting
82 enrolled